欢迎访问《微生物与感染》官方网站,今天是
综述

梅毒螺旋体疫苗的研究进展

  • 郑康1 ,
  • 刘安元1 ,
  • 2 ,
  • 吴移谋1
展开
  • 1. 南华大学衡阳医学院病原生物学研究所, 衡阳 421001; 2. 南华大学附属第二医院, 衡阳 421001

收稿日期: 2019-04-22

  网络出版日期: 2019-06-25

基金资助

国家自然科学基金(81471576、81702046)

Vaccine development for syphilis

  • ZHENG Kang1 ,
  • LIU Anyuan1 ,
  • 2 ,
  • WU Yimou1
Expand
  • 1. Institution of Pathogenic Biology, Medical College, University of South China, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, 421001, China; 2. The Second Affiliated Hospital of University of South China, Hengyang 421001, China

Received date: 2019-04-22

  Online published: 2019-06-25

摘要

梅毒是由密螺旋体苍白亚种(Treponema pallidum subsp. pallidum, Tp)感染引起的慢性系统性性传播疾病,流行于中低等收入国家。越来越多的临床病例表明清除Tp感染需要加强公共卫生筛查和治疗,而接种疫苗是预防Tp感染极有价值和首选的方法。本文概述了研制Tp疫苗的必要性,总结疫苗研究过程中候选抗原的相关信息及递送系统,分析Tp疫苗发展策略。

本文引用格式

郑康1 , 刘安元1 , 2 , 吴移谋1 . 梅毒螺旋体疫苗的研究进展[J]. 微生物与感染, 2019 , 14(3) : 180 -184 . DOI: 10.3969/j.issn.1673-6184.2019.03.007

Abstract

Syphilis is a sexually transmitted infection caused by Treponema pallidum subsp. Pallidum (T. pallidum), Over 90% of syphilis cases occur in low- and middle-income countries. Studies indicated that elimination of T. pallidum requires enhanced public health screening, treatment and vaccination. This article provides an overview of the need for development of a syphilis vaccine, summarizes the information and delivery system and candidate antigens in development, and analyzes the development strategies for T. pallidum vaccine.
文章导航

/